A review on recipients of hematopoietic stem cell transplantation patients with COVID-19 infection
- PMID: 33996075
- PMCID: PMC8111517
- DOI: 10.1177/20499361211013252
A review on recipients of hematopoietic stem cell transplantation patients with COVID-19 infection
Abstract
For the last few months, various geographical regions and health sectors have been facing challenges posed by the current COVID-19 pandemic. COVID-19 has led to significant disruption in the normal functioning of potentially life-saving therapies of hematopoietic cell transplant and chimeric antigen receptor therapy. As transplant physicians are gaining more information and experience regarding the undertaking of these complex procedures during the ongoing COVID-19 pandemic, we believe it is important to discuss the challenges faced, prognostic risk factors, and outcomes of COVID-19 in post-hematopoietic stem cell transplantation patients based on the available real-world data.
Keywords: COVID-19; Cancer; stem cell transplantation; virus.
© The Author(s), 2021.
Conflict of interest statement
Conflict of interest statement: The authors declare that there is no conflict of interest.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
